Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Birgitta Stellan
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated With Upregulated Decoy TRAIL Receptor Expression in Patients With Multiple Myeloma
PLoS ONE
Multidisciplinary
Related publications
Surface TRAIL Decoy Receptor-4 Expression Is Correlated With TRAIL Resistance in McF7 Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Is Edentulism Associated With Lower Bacteremia and Transplant-Associated Toxicities in Patients With Multiple Myeloma?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
ACE Insertion/Deletion Polymorphism (Rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
Frontiers in Oncology
Cancer Research
Oncology
High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib
Blood Cancer Journal
Oncology
Hematology
Oculomotor Nerve Palsy Associated With Bortezomib in a Patient With Multiple Myeloma: A Case Report
Journal of Medical Case Reports
Medicine
Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma
BMC Cancer
Cancer Research
Oncology
Genetics
Bortezomib for the Treatment of Multiple Myeloma Patients
Health Technology Assessment
Medicine
Health Policy
